ScholarIQanswers from OpenAlex & ORCID
Klaus Pantel
ResearcherPublications, citations & collaboration network
Klaus Pantel is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Klaus Pantel have?
ScholarIQindexed works
Klaus Pantel has 1,504 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Klaus Pantel have?
ScholarIQcitation count
Klaus Pantel has 83,229 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Klaus Pantel?
ScholarIQh-index
Klaus Pantel has an h-index of 140 in OpenAlex.
What is the i10-index of Klaus Pantel?
ScholarIQi10-index
Klaus Pantel has an i10-index of 592 in OpenAlex.
What is the ORCID of Klaus Pantel?
ScholarIQorcid
The ORCID for Klaus Pantel is on the source record.
What is the OpenAlex record for Klaus Pantel?
ScholarIQopenalex
The OpenAlex for Klaus Pantel is on the source record.
What are the most-cited papers on Klaus Pantel?
ScholarIQmost cited works
Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
Irène Baccelli, Andreas Schneeweiß, Sabine Riethdorf, Albrecht Stenzinger, Anja Schillert, Vanessa Vogel, Corinna Klein, Massimo Saini, Tobias Bäuerle, Markus Wallwiener, Tim Holland‐Letz, Thomas Höfner, Martin R. Sprick, Martina Scharpff, Frederik Marmé, Hans‐Peter Sinn, Klaus Pantel, Wilko Weichert, Andreas Trumpp
ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group
Javier Pascual, Gerhardt Attard, François‐Clément Bidard, Giuseppe Curigliano, Leticia De Mattos‐Arruda, Maximilian Diehn, Antoîne Italiano, Johan Lindberg, Jason D. Merker, Clara Montagut, Nicola Normanno, Klaus Pantel, George Pentheroudakis, Sanjay Popat, Jorge S. Reis‐Filho, Jeanne Tie, Joan Seoane, N. Tarazona, Takayuki Yoshino, Nicholas C. Turner
Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer
Wolfgang Janni, Brigitte Rack, Leon W.M.M. Terstappen, Jean‐Yves Pierga, Florin‐Andrei Taran, Tanja Fehm, Carolyn Hall, Marco R. de Groot, François‐Clément Bidard, Thomas W. P. Friedl, Peter A. Fasching, Sara Y. Brucker, Klaus Pantel, Anthony Lucci
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
François‐Clément Bidard, Stefan Michiels, Sabine Riethdorf, Volkmar Müller, Laura J. Esserman, Anthony Lucci, Bjørn Naume, Jun Horiguchi, Rafael Gisbert‐Criado, Stefan Sleijfer, Masakazu Toi, José Á. García-Sáenz, Andreas D. Hartkopf, Daniele Generali, Françoise Rothé, Jeffrey B. Smerage, Laura Muinelo‐Romay, Justin Stebbing, Patrice Viens, Mark Jesus M. Magbanua, Carolyn Hall, Olav Engebraaten, Daisuke Takata, José Vidal-Martínez, Wendy Onstenk, Noriyoshi Fujisawa, Eduardo Díaz‐Rubio, Florin‐Andrei Taran, Maria Rosa Cappelletti, Michail Ignatiadis, Charlotte Proudhon, Denise M. Wolf, Jessica B. Bauldry, Elin Borgen, Rin Nagaoka, Vicente Carañana, Jaco Kraan, Marisa Maestro, Sara Y. Brucker, Karsten E. Weber, Fabien Reyal, Dominic Amara, Mandar Karhade, Randi R. Mathiesen, H. Tokiniwa, Antonio Llombart‐Cussac, Alessandra Meddis, Paul Blanche, Koenraad D’Hollander, Paul Cottu, John W. Park, Sibylle Loibl, Aurélien Latouche, Jean‐Yves Pierga, Klaus Pantel
Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer
Catherine Alix‐Panabières, Jean-Pierre Vendrell, Monique Slijper, Olivier Pellé, E. Barbotte, Grégoire Mercier, William Jacot, Michel Fabbro, Klaus Pantel